Paul Hastings, a leading global law firm, announced today that it represented Shuanghui International Holdings Limited (“Shuanghui International”) and its subsidiaries (collectively, the “Shuanghui Group”), including Henan Shuanghui Investment Development Co. Ltd. (“Shuanghui Investment”) which is an A-share company listed on the Shenzhen Stock Exchange, in one of the largest public company merger and acquisition transactions in China. The Shuanghui Group is a large-scale food processing company in China whose major shareholders include CDH Investments, Goldman Sachs, Temasek (the Singapore government’s investment firm) and New Horizon (a leading China-focused private equity fund).
Tags: Paul Hastings, LLP | Hong Kong O’Melveny Represents China Polymetallic Mining Limited in HK$1.46 Billion (US$187 Million) IPO Listing in Hong Kong
O’Melveny & Myers represented China Polymetallic Mining Limited (HKSE:2133) in its HK$1.46 billion (US$187 million) initial public offering on the Main Board of the Hong Kong Stock Exchange.
Tags: O'Melveny & Myers, LLP | Hong Kong Freshfields Advises on China’s First Insurance Company Rights Issue
International law firm Freshfields Bruckhaus Deringer has advised the underwriters on PICC Property & Casualty Company Limited’s domestic share and H-share rights issue.
Tags: Freshfields LLP | Hong Kong Eversheds HK Advises on RMB 2.36bn (US$932m) Acquisition
International law firm Eversheds has advised Chow Tai Fook Enterprises Ltd on a RMB 2.36bn (US$932m)property deal to acquire 100 percent stake in a Qingdao-based joint venture from Shanghai Industrial Holdings Limited, a company listed on the Hong Kong Stock Exchange.
Tags: Eversheds Sutherland | Hong Kong Davis Polk Advises New China Life Insurance Company Ltd. on Its US$1.9 Billion Initial Public Offering
Davis Polk advised New China Life Insurance Company Ltd. (NCI) on its US$1.9 billion initial public offering (IPO), including a global offering of H shares, consisting of an initial public offering on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A and Regulation S, and a concurrent offering of A shares listed on the Shanghai Stock Exchange. The IPO, with total proceeds of nearly US$2.1 billion if the over-allotment option is fully exercised, is one of the largest initial public offerings of PRC companies and the only concurrent A + H shares offering in 2011.
Tags: Davis Polk & Wardwell LLP | Hong Kong King & Wood Mallesons – A New Legal Powerhouse for Asia
Mallesons Stephen Jaques and King & Wood have announced the combination of their firms to create King & Wood Mallesons, a new legal powerhouse centred in Asia.
Tags: King & Wood Mallesons | Hong Kong Freshfields Advises Chow Tai Fook Jewellery Group Limited on Its US$2bn IPO
International law firm Freshfields Bruckhaus Deringer has advised Chow Tai Fook Jewellery Group Limited on its US$2 billion global offering of shares and listing on the Hong Kong Stock Exchange.
Tags: Freshfields LLP | Hong Kong Herbert Smith Advises China Outfitters Holdings Limited on Its HK$1.13 Billion IPO
International law firm Herbert Smith has recently advised China Outfitters Holdings Limited (“China Outfitters”; HK Stock Code: 1146) on the HK$1.13 billion (US$145 million) listing of its shares on the main board of the Hong Kong Stock Exchange and Rule 144A/Regulation S global offering. The IPO was completed on 9 December 2011.
Tags: Herbert Smith Freehills Kramer LLP | Hong Kong Linklaters Advises on First Offshore RMB Bond Issue by a PRC Corporate
Linklaters has advised on the first offshore RMB bond issue by a PRC corporate. The groundbreaking RMB 3.6bn three-tranche dated senior unsubordinated debut issue of Baosteel Group Corporation, a Fortune Global 500 company with one of the highest ratings among PRC corporates (A3 by Moody’s, A by S&P and A – by Fitch) is also the largest ever offshore RMB corporate bond offering to date, illustrating the depth of the rapidly expanding offshore RMB bond market.
Tags: Linklaters LLP | Hong Kong Paul Hastings Represents Dong-A Pharmaceutical on Strategic Collaboration Partnership with Meiji
Paul Hastings LLP, a leading global law firm, announced today that it advised Dong-A Pharmaceutical Co., Ltd. (Dong-A), a leading Korean pharmaceutical company, on its long-term strategic collaboration partnership with Meiji Seika Pharma Co., Ltd (Meiji), a Japanese pharmaceutical company, with respect to biosimilars.
Tags: Paul Hastings, LLP | Hong Kong 







